Kalofonos Isabel
Reporting owner on Forms 3, 4 and 5, CIK 1975163.
Kalofonos Isabel reported on 1 issuer in 3 filings, the latest a Form 4 filed 2026-11-18.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CGON · CG Oncology, Inc.CIK 1991792 | officer (Chief Commercial Officer) | 2 | 2026-11-18 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CGON · CG Oncology, Inc.Common Stock | 2026-11-18 | P bought | +3,751 | $79.755 | 3,751 | Form 4 |
| CGON · CG Oncology, Inc.Employee Stock Option (right to buy), derivative | 2026-10-15 | A granted | +92,000 | $0 | 92,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-467159 | CG Oncology, Inc. | 2026-11-18 | ||
| Form 4 0001193125-26-425297 | CG Oncology, Inc. | 2026-10-19 | ||
| Form 3 0001193125-26-425256 | CG Oncology, Inc. | 2026-10-19 |